Nicolás Urtasun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nicolás Urtasun has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- María Fernanda Baieli
Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956, Buenos Aires C1113AAD, Argentina
10 shared publications Osvaldo Cascone
10 shared publicationsMaría V. Miranda
8 shared publicationsFederico J. Wolman
4 shared publicationsFederico Javier Wolman
4 shared publications- María Camila Martínez Ceron
Universidad de Buenos Aires, Facultad de Ingeniería, Grupo de Biomateriales para Prótesis, Ingeniería de Tejidos y Microfluídica, Instituto de Ingeniería Biomédica, Buenos Aires 1063, Argentina
4 shared publications
Latest Publications
- 1 October 2020
- Published by Elsevier in International Dairy Journal
- Vol. 109
Lactoferrin purification and whey protein isolate recovery from cheese whey using chitosan mini-spheres
- 1 October 2020
- Published by Elsevier in International Dairy Journal
- Vol. 109
Lactoferrin purification and whey protein isolate recovery from cheese whey using chitosan mini-spheres
- 5 October 2018
- Published by Wiley in Journal of Peptide Science
- Vol. 24 (11) , e3128
Recombinant human follicle stimulating hormone purification by a short peptide affinity chromatography
Peptide KVPLITVSKAK was selected to design a synthetic ligand for affinity chromatography purification of recombinant human follicle stimulating hormone (rhFSH), based on the interaction of the hormone with the exoloop 3 of its receptor. The peptide was acetylated to improve its stability to degradation by exopeptidases. A cysteine was incorporated at the C‐termini to facilitate its immobilization to the chromatographic activated SulfoLink agarose resin. A sample of crude rhFSH was loaded to the affinity column, using 20 mM sodium phosphate, 0.5 mM methionine, and pH 5.6 and 7.2 as adsorption and elution buffers, respectively. The dynamic capacity of the matrix was 54.6 mg rhFSH/mL matrix and the purity 94%. The percentage of oxidized rhFSH was 3.4%, and that of the free subunits was 1.2%, both in the range established by the European Pharmacopeia, as also were the sialic acid content and the isoforms profile.
- 5 October 2018
- Published by Wiley in Journal of Peptide Science
- Vol. 24 (11) , e3128
Recombinant human follicle stimulating hormone purification by a short peptide affinity chromatography
Peptide KVPLITVSKAK was selected to design a synthetic ligand for affinity chromatography purification of recombinant human follicle stimulating hormone (rhFSH), based on the interaction of the hormone with the exoloop 3 of its receptor. The peptide was acetylated to improve its stability to degradation by exopeptidases. A cysteine was incorporated at the C‐termini to facilitate its immobilization to the chromatographic activated SulfoLink agarose resin. A sample of crude rhFSH was loaded to the affinity column, using 20 mM sodium phosphate, 0.5 mM methionine, and pH 5.6 and 7.2 as adsorption and elution buffers, respectively. The dynamic capacity of the matrix was 54.6 mg rhFSH/mL matrix and the purity 94%. The percentage of oxidized rhFSH was 3.4%, and that of the free subunits was 1.2%, both in the range established by the European Pharmacopeia, as also were the sialic acid content and the isoforms profile.
- Open Access
- 7 December 2017
- Published by Wiley in Biotechnology Progress
- Vol. 34 (2) , 387-396
Sulfanilic acid‐modified chitosan mini‐spheres and their application for lysozyme purification from egg white
A cation exchange matrix with zwitterionic and multimodal properties was synthesized by a simple reaction sequence coupling sulfanilic acid to a chitosan based support. The novel chromatographic matrix was physico‐chemically characterized by ss‐NMR and ζ potential, and its chromatographic performance was evaluated for lysozyme purification from diluted egg white. The maximum adsorption capacity, calculated according to Langmuir adsorption isotherm, was 50.07 ± 1.47 mg g −1 while the dissociation constant was 0.074 ± 0.012 mg mL −1 . The process for lysozyme purification from egg white was optimized, with 81.9% yield and a purity degree of 86.5%, according to RP‐HPLC analysis. This work shows novel possible applications of chitosan based materials. The simple synthesis reactions combined with the simple mode of use of the chitosan matrix represents a novel method to purify proteins from raw starting materials. © 2017 American Institute of Chemical Engineers Biotechnol. Prog. , 34:387–396, 2018
- 7 December 2017
- Published by Wiley in Biotechnology Progress
- Vol. 34 (2) , 387-396
Open AccessSulfanilic acid‐modified chitosan mini‐spheres and their application for lysozyme purification from egg white
A cation exchange matrix with zwitterionic and multimodal properties was synthesized by a simple reaction sequence coupling sulfanilic acid to a chitosan based support. The novel chromatographic matrix was physico‐chemically characterized by ss‐NMR and ζ potential, and its chromatographic performance was evaluated for lysozyme purification from diluted egg white. The maximum adsorption capacity, calculated according to Langmuir adsorption isotherm, was 50.07 ± 1.47 mg g −1 while the dissociation constant was 0.074 ± 0.012 mg mL −1 . The process for lysozyme purification from egg white was optimized, with 81.9% yield and a purity degree of 86.5%, according to RP‐HPLC analysis. This work shows novel possible applications of chitosan based materials. The simple synthesis reactions combined with the simple mode of use of the chitosan matrix represents a novel method to purify proteins from raw starting materials. © 2017 American Institute of Chemical Engineers Biotechnol. Prog. , 34:387–396, 2018
- 1 May 2017
- Published by Elsevier in Food and Bioproducts Processing
- Vol. 103, 58-65
Lactoperoxidase purification from whey by using dye affinity chromatography
- 1 May 2017
- Published by Elsevier in Food and Bioproducts Processing
- Vol. 103, 58-65
Lactoperoxidase purification from whey by using dye affinity chromatography
- 29 November 2016
- Published by Wiley in Biotechnology Progress
- Vol. 33 (1) , 171-180
Affinity chromatography matrices for depletion and purification of casein glycomacropeptide from bovine whey
Casein glycomacropeptide (CMP) is a 64‐ amino acid peptide found in cheese whey, which is released after κ‐casein specific cleavage by chymosin. CMP lacks aromatic amino acids, a characteristic that makes it usable as a nutritional supplement for people with phenylketonuria. CMP consists of two nonglycosylated isoforms (aCMP A and aCMP B) and its different glycosylated forms (gCMP A and gCMP B). The most predominant carbohydrate of gCMP is N ‐acetylneuraminic acid (sialic acid). Here, we developed a CMP purification process based on the affinity of sialic acid for wheat germ agglutinin (WGA). After formation of chitosan beads and adsorption of WGA, the agglutinin was covalently attached with glutaraldehyde. Two matrices with different WGA density were assayed for CMP adsorption. Maximum adsorption capacities were calculated according to the Langmuir model from adsorption isotherms developed at pH 7.0, being 137.0 mg/g for the matrix with the best performance. In CMP reduction from whey, maximum removal percentage was 79% (specifically 33.7% of gCMP A and B, 75.8% of aCMP A, and 93.9% of aCMP B). The CMP was recovered as an aggregate with an overall yield of 64%. Therefore, the matrices developed are promising for CMP purification from cheese whey. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 33:171–180, 2017
- 29 November 2016
- Published by Wiley in Biotechnology Progress
- Vol. 33 (1) , 171-180
Affinity chromatography matrices for depletion and purification of casein glycomacropeptide from bovine whey
Casein glycomacropeptide (CMP) is a 64‐ amino acid peptide found in cheese whey, which is released after κ‐casein specific cleavage by chymosin. CMP lacks aromatic amino acids, a characteristic that makes it usable as a nutritional supplement for people with phenylketonuria. CMP consists of two nonglycosylated isoforms (aCMP A and aCMP B) and its different glycosylated forms (gCMP A and gCMP B). The most predominant carbohydrate of gCMP is N ‐acetylneuraminic acid (sialic acid). Here, we developed a CMP purification process based on the affinity of sialic acid for wheat germ agglutinin (WGA). After formation of chitosan beads and adsorption of WGA, the agglutinin was covalently attached with glutaraldehyde. Two matrices with different WGA density were assayed for CMP adsorption. Maximum adsorption capacities were calculated according to the Langmuir model from adsorption isotherms developed at pH 7.0, being 137.0 mg/g for the matrix with the best performance. In CMP reduction from whey, maximum removal percentage was 79% (specifically 33.7% of gCMP A and B, 75.8% of aCMP A, and 93.9% of aCMP B). The CMP was recovered as an aggregate with an overall yield of 64%. Therefore, the matrices developed are promising for CMP purification from cheese whey. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 33:171–180, 2017
- 3 March 2016
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 17 (5) , 431-438
Insect Larvae: A New Platform to Produce Commercial Recombinant Proteins
In Biotechnology, the expression of recombinant proteins is a constantly growing field and different hosts are used for this purpose. Some valuable proteins cannot be produced using traditional systems. Insects from the order Lepidoptera infected with recombinant baculovirus have appeared as a good choice to express high levels of proteins, especially those with post-translational modifications. Lepidopteran insects, which are extensively distributed in the world, can be used as small protein factories, the new biofactories. Species like Bombyx mori (silkworm) have been analyzed in Asian countries to produce a great number of recombinant proteins for use in basic and applied science and industry. Many proteins expressed in this larva have been commercialized. Several recombinant proteins produced in silkworms have already been commercialized. On the other hand, species like Spodoptera frugiperda, Heliothis virescens, Rachiplusia nu, Helicoverpa zea and Trichoplusia ni are widely distributed in both the occidental world and Europe. The expression of recombinant proteins in larvae has the advantage of its low cost in comparison with insect cell cultures. A wide variety of recombinant proteins, including enzymes, hormones and vaccines, have been efficiently expressed with intact biological activity. The expression of pharmaceutically proteins, using insect larvae or cocoons, has become very attractive. This review describes the use of insect larvae as an alternative to produce commercial recombinant proteins.
- 3 March 2016
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 17 (5) , 431-438
Insect Larvae: A New Platform to Produce Commercial Recombinant Proteins
In Biotechnology, the expression of recombinant proteins is a constantly growing field and different hosts are used for this purpose. Some valuable proteins cannot be produced using traditional systems. Insects from the order Lepidoptera infected with recombinant baculovirus have appeared as a good choice to express high levels of proteins, especially those with post-translational modifications. Lepidopteran insects, which are extensively distributed in the world, can be used as small protein factories, the new biofactories. Species like Bombyx mori (silkworm) have been analyzed in Asian countries to produce a great number of recombinant proteins for use in basic and applied science and industry. Many proteins expressed in this larva have been commercialized. Several recombinant proteins produced in silkworms have already been commercialized. On the other hand, species like Spodoptera frugiperda, Heliothis virescens, Rachiplusia nu, Helicoverpa zea and Trichoplusia ni are widely distributed in both the occidental world and Europe. The expression of recombinant proteins in larvae has the advantage of its low cost in comparison with insect cell cultures. A wide variety of recombinant proteins, including enzymes, hormones and vaccines, have been efficiently expressed with intact biological activity. The expression of pharmaceutically proteins, using insect larvae or cocoons, has become very attractive. This review describes the use of insect larvae as an alternative to produce commercial recombinant proteins.
- 1 January 2015
- Published by Elsevier in Process Biochemistry
- Vol. 50 (1) , 40-47
High-level expression and purification of recombinant wheat germ agglutinin in Rachiplusia nu larvae
- 1 January 2015
- Published by Elsevier in Process Biochemistry
- Vol. 50 (1) , 40-47
High-level expression and purification of recombinant wheat germ agglutinin in Rachiplusia nu larvae
- 1 November 2014
- Published by Elsevier in International Dairy Journal
- Vol. 39 (1) , 53-59
Isolation of lactoferrin from whey by dye-affinity chromatography with Yellow HE-4R attached to chitosan mini-spheres
- 1 November 2014
- Published by Elsevier in International Dairy Journal
- Vol. 39 (1) , 53-59
Isolation of lactoferrin from whey by dye-affinity chromatography with Yellow HE-4R attached to chitosan mini-spheres